The SAFE vs convertible note debate sounds technical. It isn't. One is debt. One isn't. That's almost the whole story.
Y Combinator invented the SAFE (Simple Agreement for Future Equity) in 2013 specifically to replace convertible notes. The pitch was simple: strip out the interest, the maturity date, and the debt structure — and give founders a cleaner instrument that still lets investors participate before a valuation is set. It worked. Over 80% of YC-batch companies now raise on SAFEs, and the post-money SAFE has become the default pre-equity instrument across Silicon Valley.
But convertible notes haven't disappeared. They're still common in markets outside the Bay Area, with certain institutional investors who prefer debt treatment for accounting reasons, and in situations where a founder needs to raise bridge capital quickly with a familiar structure. Understanding when to use each instrument — and what the downstream consequences are — matters more than people admit.
SAFE vs Convertible Note: The Core Differences
| Feature | SAFE | Convertible Note |
|---|---|---|
| Instrument type | Equity contract | Debt (promissory note) |
| Interest rate | None | 6–8% per year, typically |
| Maturity date | None | 18–24 months |
| Repayment risk | No repayment required | Can be called at maturity |
| Valuation cap | Standard | Standard |
| Discount | Optional (10–30%) | Optional (10–30%) |
| Legal complexity | Low — 5 page doc | Higher — negotiated note + term sheet |
| Tax/accounting | Equity treatment | Debt on balance sheet |
| MFN clause | Common (post-money SAFE) | Negotiated |
| Pro-rata rights | Optional side letter | Often included |
When to Use a SAFE
For the vast majority of US pre-seed and seed rounds, use a SAFE. The reasons are straightforward:
No debt pressure
There's no maturity date forcing you to raise a priced round or face repayment. You can take the time the company needs.
Simpler documents
YC's standard SAFE is five pages. A convertible note with side letters can run 20+ pages and require a securities attorney on both sides.
No interest accrual
Every day a convertible note sits outstanding, interest accrues. On a $1M note at 7%, that's $70K/year in additional dilution at conversion.
Founder-standard in 2026
Any sophisticated seed investor in the US expects to see a SAFE. Offering a convertible note raises questions about why you're deviating from the norm.
The post-money SAFE — where the cap is calculated on a post-money basis including all SAFEs raised — has become the standard because it makes dilution modeling predictable. Founders know exactly how much they're giving up before a Series A closes.
When a Convertible Note Makes Sense
Convertible notes aren't obsolete — there are specific situations where they're the right instrument:
- →Investor requires it: Some angel investors and seed funds — particularly outside Silicon Valley — have standard documentation that uses convertible notes. It's often not worth arguing.
- →Accounting or regulatory preference: Certain institutional LPs, family offices, and international investors prefer debt treatment for accounting, tax, or regulatory reasons in their home jurisdiction.
- →Bridge round to a known priced round: If you're raising a $500K bridge to cover three months while a Series A closes, a convertible note with a short maturity tied to the expected close date can be cleaner than a SAFE.
- →States where SAFEs aren't established securities: In some non-US markets and a handful of US states, SAFEs have less legal precedent. A convertible note fits neatly into established securities law frameworks.
What Happens at Scale: The Cap Table Problem
The instrument you pick in a $500K round feels trivial until you've raised four rounds and a Series A investor is trying to model your cap table. This is where SAFE-heavy seed rounds create real complexity.
Every SAFE converts independently with its own cap, discount, and MFN rights. If you raised eight SAFEs at different caps over 24 months — which is common in rolling seed rounds — a Series A investor needs to model eight separate conversion calculations simultaneously, each triggered by the same priced round.
Most Sophisticated investors prefer to see a clean seed round with one or two SAFEs at standard terms rather than a collection of instruments with different caps. The rule of thumb I use: if you have more than three different SAFE caps on your cap table before a Series A, you have a structuring problem.
Clean Cap Table Before Series A
- ✓ 1–2 SAFE tranches at similar caps
- ✓ One standard MFN provision
- ✓ Pro-rata rights via a clean side letter
- ✓ Post-money SAFEs so dilution is calculable
Cap Table Complexity Warning Signs
- ✕ 5+ SAFEs with different caps and vintages
- ✕ Mix of pre-money and post-money SAFEs
- ✕ Convertible notes near or past maturity
- ✕ MFN provisions triggering conflicting adjustments
The Key Terms on Either Instrument
Whether you use a SAFE or convertible note, these are the three terms that drive the economics:
Valuation cap
The maximum price at which the instrument converts. A $10M cap on a $5M raise means each investor's share is calculated as if the company's pre-money valuation is $10M, regardless of what Series A investors actually pay. Caps should reflect the company's realistic value at investment — not an aspirational future.
Discount rate
A percentage reduction on the Series A price for early investors. A 20% discount means early investors pay $0.80 per share when the Series A closes at $1.00 per share. Most sophisticated investors prefer a cap to a discount because a cap scales with your success — a discount is fixed regardless of outcome.
MFN clause
Most Favored Nation provisions require the company to update earlier investors' terms if later investors get better terms. On a rolling seed round with multiple SAFEs, this can cascade unexpectedly — an investor who signs a SAFE at a $10M cap can invoke MFN to claim a $7M cap you gave a later investor.
The instrument matters less than the terms.
A SAFE with an unrealistic cap is worse than a convertible note with fair terms. Pick the instrument that fits your investors, then negotiate the cap as if it were your actual equity price — because at conversion, it is.
Track startup funding structures and valuations on the Startup Funding Dashboard at Value Add VC. Originally published in the Trace Cohen newsletter.